These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25582014)

  • 1. [Exome sequencing revealed Allan-Herndon-Dudley syndrome underlying multiple disabilities].
    Arvio M; Philips AK; Ahvenainen M; Somer M; Kalscheuer V; Järvelä I
    Duodecim; 2014; 130(21):2202-5. PubMed ID: 25582014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The importance of thyroid hormone transporters].
    Braun D
    Nuklearmedizin; 2015; 54(3):77-81. PubMed ID: 26105714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.
    Kobayashi S; Onuma A; Inui T; Wakusawa K; Tanaka S; Shimojima K; Yamamoto T; Haginoya K
    Pediatr Neurol; 2014 Sep; 51(3):414-6. PubMed ID: 25160547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene.
    La Piana R; Vanasse M; Brais B; Bernard G
    J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.
    Boccone L; Dessì V; Meloni A; Loudianos G
    Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].
    Tang YL; Peng J; Xiong J; Pang N; Wu LW; Yang HY; Kessi M; Yin F
    Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):829-834. PubMed ID: 30392207
    [No Abstract]   [Full Text] [Related]  

  • 7. Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation.
    Armour CM; Kersseboom S; Yoon G; Visser TJ
    PLoS One; 2015; 10(10):e0139343. PubMed ID: 26426690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
    Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
    Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel A178P mutation in SLC16A2 in a patient with Allan-Herndon-Dudley syndrome.
    Yamamoto T; Lu Y; Nakamura R; Shimojima K; Kira R
    Congenit Anom (Kyoto); 2018 Jul; 58(4):143-144. PubMed ID: 28862359
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature.
    Azzolini S; Nosadini M; Balzarin M; Sartori S; Suppiej A; Mardari R; Greggio NA; Toldo I
    Brain Dev; 2014 Sep; 36(8):716-20. PubMed ID: 24268987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH.
    Boccone L; Mariotti S; Dessì V; Pruna D; Meloni A; Loudianos G
    Eur J Med Genet; 2010; 53(6):392-5. PubMed ID: 20713192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent Esotropia in 4 Patients With Allan-Herndon-Dudley Syndrome.
    Swiston CJ; Nash DL
    J Child Neurol; 2018 Jul; 33(8):525-527. PubMed ID: 29714107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First female with Allan-Herndon-Dudley syndrome and partial deletion of X-inactivation center.
    Quesada-Espinosa JF; Garzón-Lorenzo L; Lezana-Rosales JM; Gómez-Rodríguez MJ; Sánchez-Calvin MT; Palma-Milla C; Gómez-Manjón I; Hidalgo-Mayoral I; Pérez de la Fuente R; Arteche-López A; Álvarez-Mora MI; Camacho-Salas A; Cruz-Rojo J; Lázaro-Rodríguez I; Morales-Conejo M; Nuñez-Enamorado N; Bustamante-Aragones A; Simón de Las Heras R; Gomez-Cano MA; Ramos-Gómez P; Sierra-Tomillo O; Juárez-Rufián A; Gallego-Merlo J; Rausell-Sánchez L; Moreno-García M; Sánchez Del Pozo J
    Neurogenetics; 2021 Oct; 22(4):343-346. PubMed ID: 34296368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
    Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
    Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
    Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
    Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of exon 1 of the SLC16A2 gene: a common occurrence in patients with Allan-Herndon-Dudley syndrome.
    García-de Teresa B; González-Del Angel A; Reyna-Fabián ME; Ruiz-Reyes Mde L; Calzada-León R; Pérez-Enríquez B; Alcántara-Ortigoza MA
    Thyroid; 2015 Mar; 25(3):361-7. PubMed ID: 25517855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel
    Mahesan A; Kamila G; Choudhary P; Jauhari P; Chakrabarty B; Kumar A; Gulati S
    Neurol India; 2023; 71(6):1282-1283. PubMed ID: 38174482
    [No Abstract]   [Full Text] [Related]  

  • 18. Disorder of thyroid hormone transport into the tissues.
    Groeneweg S; Visser WE; Visser TJ
    Best Pract Res Clin Endocrinol Metab; 2017 Mar; 31(2):241-253. PubMed ID: 28648511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.
    Frints SG; Lenzner S; Bauters M; Jensen LR; Van Esch H; des Portes V; Moog U; Macville MV; van Roozendaal K; Schrander-Stumpel CT; Tzschach A; Marynen P; Fryns JP; Hamel B; van Bokhoven H; Chelly J; Beldjord C; Turner G; Gecz J; Moraine C; Raynaud M; Ropers HH; Froyen G; Kuss AW
    Eur J Hum Genet; 2008 Sep; 16(9):1029-37. PubMed ID: 18398436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.